Paula Greene
Adult Health · Jupiter, FLNPI 1023235728
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,874 of the $4,347 with a category attached, or 89.1%. It is spread thinly across 37 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations.
Across 205 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$502
- Daiichi Sankyo Inc.$445
- Merck$384
- Astellas Pharma US Inc$376
- Novartis$345
- Incyte Corporation$231
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,87489%
- Education$47411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $502 |
| Daiichi Sankyo Inc. | 17 | $445 |
| Merck | 16 | $384 |
| Astellas Pharma US Inc | 13 | $376 |
| Novartis | 34 | $345 |
| Incyte Corporation | 14 | $231 |
| Sobi, Inc | 8 | $230 |
| Johnson & Johnson | 13 | $212 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $196 |
| Eisai Inc. | 8 | $150 |
| Exelixis Inc. | 3 | $141 |
| Lilly USA, LLC | 6 | $130 |
| Pfizer | 6 | $104 |
| Jazz Pharmaceuticals Inc. | 3 | $74 |
| Boehringer Ingelheim | 3 | $68 |
| Stemline Therapeutics Inc. | 3 | $67 |
| GSK | 3 | $65 |
| Tersera Therapeutics LLC | 2 | $63 |
| Bristol Myers Squibb | 2 | $53 |
| Bayer | 3 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $49 |
| Genentech USA, Inc. | 2 | $46 |
| Legend Biotech USA Inc. | 2 | $44 |
| Taiho Oncology, Inc. | 2 | $36 |
| Sanofi | 1 | $32 |
| Gilead | 1 | $32 |
| Deciphera Pharmaceuticals Inc. | 1 | $27 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| AbbVie | 1 | $23 |
| Beigene USA, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Agios Pharmaceuticals, Inc. | 1 | $17 |
| Pharmaessentia USA Corporation | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
| Novocure Inc. | 1 | $15 |
How this compares
$4,347 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Other adult health in Jupiter
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.